SMC5_HUMAN - dbPTM
SMC5_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID SMC5_HUMAN
UniProt AC Q8IY18
Protein Name Structural maintenance of chromosomes protein 5
Gene Name SMC5
Organism Homo sapiens (Human).
Sequence Length 1101
Subcellular Localization Nucleus . Chromosome . Nucleus, PML body . Chromosome, telomere . Associates with chromatin (PubMed:25931565). Colocalizes with SMC6 on the X-Y chromosome pair within the sex vesicle during late pachytene/diplotene (By similarity). Localizes to PML n
Protein Description Core component of the SMC5-SMC6 complex, a complex involved in repair of DNA double-strand breaks by homologous recombination. The complex may promote sister chromatid homologous recombination by recruiting the SMC1-SMC3 cohesin complex to double-strand breaks. The complex is required for telomere maintenance via recombination in ALT (alternative lengthening of telomeres) cell lines and mediates sumoylation of shelterin complex (telosome) components which is proposed to lead to shelterin complex disassembly in ALT-associated PML bodies (APBs). Required for recruitment of telomeres to PML nuclear bodies. Required for sister chromatid cohesion during prometaphase and mitotic progression; the function seems to be independent of SMC6. SMC5-SMC6 complex may prevent transcription of episomal DNA, such as circular viral DNA genome. [PubMed: 26983541]
Protein Sequence MATPSKKTSTPSPQPSKRALPRDPSSEVPSKRKNSAPQLPLLQSSGPFVEGSIVRISMENFLTYDICEVSPGPHLNMIVGANGTGKSSIVCAICLGLAGKPAFMGRADKVGFFVKRGCSRGMVEIELFRASGNLVITREIDVAKNQSFWFINKKSTTQKIVEEKVAALNIQVGNLCQFLPQDKVGEFAKLSKIELLEATEKSIGPPEMHKYHCELKNLREKEKQLETSCKEKTEYLQKMVQRNERYKQDVERFYERKRHLDLIEMLEAKRPWVEYENVRQEYEEVKLVRDRVKEEVRKLKEGQIPVTCRIEEMENERHNLEARIKEKATDIKEASQKCKQKQDVIERKDKHIEELQQALIVKQNEELDRQRRIGNTRKMIEDLQNELKTTENCENLQPQIDAITNDLRRIQDEKALCEGEIIDKRRERETLEKEKKSVDDHIVRFDNLMNQKEDKLRQRFRDTYDAVLWLRNNRDKFKQRVCEPIMLTINMKDNKNAKYIENHIPSNDLRAFVFESQEDMEVFLKEVRDNKKLRVNAVIAPKSSYADKAPSRSLNELKQYGFFSYLRELFDAPDPVMSYLCCQYHIHEVPVGTEKTRERIERVIQETRLKQIYTAEEKYVVKTSFYSNKVISSNTSLKVAQFLTVTVDLEQRRHLEEQLKEIHRKLQAVDSGLIALRETSKHLEHKDNELRQKKKELLERKTKKRQLEQKISSKLGSLKLMEQDTCNLEEEERKASTKIKEINVQKAKLVTELTNLIKICTSLHIQKVDLILQNTTVISEKNKLESDYMAASSQLRLTEQHFIELDENRQRLLQKCKELMKRARQVCNLGAEQTLPQEYQTQVPTIPNGHNSSLPMVFQDLPNTLDEIDALLTEERSRASCFTGLNPTIVQEYTKREEEIEQLTEELKGKKVELDQYRENISQVKERWLNPLKELVEKINEKFSNFFSSMQCAGEVDLHTENEEDYDKYGIRIRVKFRSSTQLHELTPHHQSGGERSVSTMLYLMALQELNRCPFRVVDEINQGMDPINERRVFEMVVNTACKENTSQYFFITPKLLQNLPYSEKMTVLFVYNGPHMLEPNTWNLKAFQRRRRRITFTQPS
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
8PhosphorylationMATPSKKTSTPSPQP
CCCCCCCCCCCCCCC
41.3827794612
9PhosphorylationATPSKKTSTPSPQPS
CCCCCCCCCCCCCCC
47.3927794612
10PhosphorylationTPSKKTSTPSPQPSK
CCCCCCCCCCCCCCC
32.7726055452
12PhosphorylationSKKTSTPSPQPSKRA
CCCCCCCCCCCCCCC
35.9323401153
16PhosphorylationSTPSPQPSKRALPRD
CCCCCCCCCCCCCCC
29.5327794612
17AcetylationTPSPQPSKRALPRDP
CCCCCCCCCCCCCCC
48.6625953088
25PhosphorylationRALPRDPSSEVPSKR
CCCCCCCCCCCCCCC
43.3425159151
26PhosphorylationALPRDPSSEVPSKRK
CCCCCCCCCCCCCCC
48.2621815630
30PhosphorylationDPSSEVPSKRKNSAP
CCCCCCCCCCCCCCC
50.7121815630
31AcetylationPSSEVPSKRKNSAPQ
CCCCCCCCCCCCCCC
62.4125953088
31UbiquitinationPSSEVPSKRKNSAPQ
CCCCCCCCCCCCCCC
62.41-
35PhosphorylationVPSKRKNSAPQLPLL
CCCCCCCCCCCCCCC
44.3425159151
44PhosphorylationPQLPLLQSSGPFVEG
CCCCCCCCCCCCCCC
36.9123927012
45PhosphorylationQLPLLQSSGPFVEGS
CCCCCCCCCCCCCCC
37.2123927012
52PhosphorylationSGPFVEGSIVRISME
CCCCCCCCEEEEECC
12.3823898821
100UbiquitinationICLGLAGKPAFMGRA
HHHHHCCCCHHCCCC
27.80-
109AcetylationAFMGRADKVGFFVKR
HHCCCCHHHEEEEEC
43.1830592491
109UbiquitinationAFMGRADKVGFFVKR
HHCCCCHHHEEEEEC
43.18-
115AcetylationDKVGFFVKRGCSRGM
HHHEEEEECCCCCCC
37.6130592497
115UbiquitinationDKVGFFVKRGCSRGM
HHHEEEEECCCCCCC
37.61-
120UbiquitinationFVKRGCSRGMVEIEL
EEECCCCCCCEEEEE
41.1022505724
142UbiquitinationVITREIDVAKNQSFW
EEEEEEEECCCCCEE
11.3923000965
157PhosphorylationFINKKSTTQKIVEEK
EEECCCCCHHHHHHH
34.65-
159UbiquitinationNKKSTTQKIVEEKVA
ECCCCCHHHHHHHHH
46.78-
180UbiquitinationGNLCQFLPQDKVGEF
CCHHHHCCCCCHHHH
41.4323000965
183UbiquitinationCQFLPQDKVGEFAKL
HHHCCCCCHHHHHHH
47.0623000965
189UbiquitinationDKVGEFAKLSKIELL
CCHHHHHHHHHHHHH
59.6223000965
192UbiquitinationGEFAKLSKIELLEAT
HHHHHHHHHHHHHHH
51.1123000965
199PhosphorylationKIELLEATEKSIGPP
HHHHHHHHHHHCCCH
34.2720068231
210UbiquitinationIGPPEMHKYHCELKN
CCCHHHHHHHHHHHH
35.0729967540
216AcetylationHKYHCELKNLREKEK
HHHHHHHHHHHHHHH
31.4826051181
216UbiquitinationHKYHCELKNLREKEK
HHHHHHHHHHHHHHH
31.4829967540
227PhosphorylationEKEKQLETSCKEKTE
HHHHHHHHHHHHHHH
48.2829083192
228PhosphorylationKEKQLETSCKEKTEY
HHHHHHHHHHHHHHH
17.5129083192
232UbiquitinationLETSCKEKTEYLQKM
HHHHHHHHHHHHHHH
31.95-
233PhosphorylationETSCKEKTEYLQKMV
HHHHHHHHHHHHHHH
30.8429083192
235PhosphorylationSCKEKTEYLQKMVQR
HHHHHHHHHHHHHHH
21.4729083192
238UbiquitinationEKTEYLQKMVQRNER
HHHHHHHHHHHHCHH
38.1421906983
254PhosphorylationKQDVERFYERKRHLD
HHHHHHHHHHHHHHH
22.5026657352
269UbiquitinationLIEMLEAKRPWVEYE
HHHHHHHCCCCCCEE
50.0129967540
275PhosphorylationAKRPWVEYENVRQEY
HCCCCCCEEHHHHHH
11.81-
282PhosphorylationYENVRQEYEEVKLVR
EEHHHHHHHHHHHHH
14.73-
286AcetylationRQEYEEVKLVRDRVK
HHHHHHHHHHHHHHH
44.5425953088
286UbiquitinationRQEYEEVKLVRDRVK
HHHHHHHHHHHHHHH
44.5433845483
300UbiquitinationKEEVRKLKEGQIPVT
HHHHHHHHCCCCCCE
63.9329967540
329PhosphorylationARIKEKATDIKEASQ
HHHHHHCHHHHHHHH
49.6929396449
350UbiquitinationDVIERKDKHIEELQQ
HHHHHHHHHHHHHHH
49.9029967540
362AcetylationLQQALIVKQNEELDR
HHHHHHHHCHHHHHH
40.1725953088
362UbiquitinationLQQALIVKQNEELDR
HHHHHHHHCHHHHHH
40.1729967540
378UbiquitinationRRIGNTRKMIEDLQN
HHHCHHHHHHHHHHH
42.0429967540
405UbiquitinationPQIDAITNDLRRIQD
HHHHHHHHHHHHHHH
39.9624816145
414AcetylationLRRIQDEKALCEGEI
HHHHHHHHHHHCCCC
55.7526051181
414UbiquitinationLRRIQDEKALCEGEI
HHHHHHHHHHHCCCC
55.7529967540
424UbiquitinationCEGEIIDKRRERETL
HCCCCCCHHHHHHHH
42.8429967540
436UbiquitinationETLEKEKKSVDDHIV
HHHHHHHHCHHHHHH
57.7229967540
443UbiquitinationKSVDDHIVRFDNLMN
HCHHHHHHHHHHHHC
4.4724816145
452UbiquitinationFDNLMNQKEDKLRQR
HHHHHCHHHHHHHHH
63.9832015554
455AcetylationLMNQKEDKLRQRFRD
HHCHHHHHHHHHHHH
46.8126051181
455UbiquitinationLMNQKEDKLRQRFRD
HHCHHHHHHHHHHHH
46.8129967540
474UbiquitinationVLWLRNNRDKFKQRV
HHHHHCCHHHHHHHH
52.6322505724
492UbiquitinationIMLTINMKDNKNAKY
EEEEEECCCCCCCCH
54.37-
495UbiquitinationTINMKDNKNAKYIEN
EEECCCCCCCCHHHH
69.30-
498UbiquitinationMKDNKNAKYIENHIP
CCCCCCCCHHHHCCC
57.0422505724
506PhosphorylationYIENHIPSNDLRAFV
HHHHCCCCCHHHHHE
42.2325159151
520UbiquitinationVFESQEDMEVFLKEV
EECCHHHHHHHHHHH
4.6823000965
534UbiquitinationVRDNKKLRVNAVIAP
HHCCCCEEEEEEECC
28.6423000965
542UbiquitinationVNAVIAPKSSYADKA
EEEEECCCCHHCCCC
42.9133845483
548AcetylationPKSSYADKAPSRSLN
CCCHHCCCCCCCCHH
54.7619608861
548UbiquitinationPKSSYADKAPSRSLN
CCCHHCCCCCCCCHH
54.7619608861
558UbiquitinationSRSLNELKQYGFFSY
CCCHHHHHHCCHHHH
34.9823000965
560PhosphorylationSLNELKQYGFFSYLR
CHHHHHHCCHHHHHH
17.8221406692
564PhosphorylationLKQYGFFSYLRELFD
HHHCCHHHHHHHHHC
22.4621406692
565PhosphorylationKQYGFFSYLRELFDA
HHCCHHHHHHHHHCC
12.4821406692
595UbiquitinationEVPVGTEKTRERIER
ECCCCCHHHHHHHHH
53.36-
610MalonylationVIQETRLKQIYTAEE
HHHHHHHHHHCCCCC
31.2126320211
610UbiquitinationVIQETRLKQIYTAEE
HHHHHHHHHHCCCCC
31.2133845483
614PhosphorylationTRLKQIYTAEEKYVV
HHHHHHCCCCCEEEE
29.2630242111
618AcetylationQIYTAEEKYVVKTSF
HHCCCCCEEEEEEEE
34.5526051181
618UbiquitinationQIYTAEEKYVVKTSF
HHCCCCCEEEEEEEE
34.5529967540
619PhosphorylationIYTAEEKYVVKTSFY
HCCCCCEEEEEEEEC
17.47-
626PhosphorylationYVVKTSFYSNKVISS
EEEEEEECCCCEECC
15.8825884760
629UbiquitinationKTSFYSNKVISSNTS
EEEECCCCEECCCCC
34.7029967540
665UbiquitinationQLKEIHRKLQAVDSG
HHHHHHHHHHHHHHH
30.6829967540
671PhosphorylationRKLQAVDSGLIALRE
HHHHHHHHHHHHHHH
28.9722210691
686AcetylationTSKHLEHKDNELRQK
HHHHHCCHHHHHHHH
53.5325953088
714AcetylationLEQKISSKLGSLKLM
HHHHHHHHHHHHHHH
50.5025953088
714UbiquitinationLEQKISSKLGSLKLM
HHHHHHHHHHHHHHH
50.5029967540
719UbiquitinationSSKLGSLKLMEQDTC
HHHHHHHHHHHCCCC
47.7032015554
740UbiquitinationRKASTKIKEINVQKA
HHHHHHHHHHHHHHH
54.84-
746UbiquitinationIKEINVQKAKLVTEL
HHHHHHHHHHHHHHH
43.11-
748AcetylationEINVQKAKLVTELTN
HHHHHHHHHHHHHHH
50.9925953088
748UbiquitinationEINVQKAKLVTELTN
HHHHHHHHHHHHHHH
50.99-
751PhosphorylationVQKAKLVTELTNLIK
HHHHHHHHHHHHHHH
35.4022817900
754PhosphorylationAKLVTELTNLIKICT
HHHHHHHHHHHHHHH
23.0322817900
779PhosphorylationLQNTTVISEKNKLES
EECCEECCCCCCCCH
37.8818491316
783UbiquitinationTVISEKNKLESDYMA
EECCCCCCCCHHHHH
65.7824816145
786PhosphorylationSEKNKLESDYMAASS
CCCCCCCHHHHHHHH
44.4730576142
788PhosphorylationKNKLESDYMAASSQL
CCCCCHHHHHHHHHH
9.6420873877
792PhosphorylationESDYMAASSQLRLTE
CHHHHHHHHHHHHHH
14.7425159151
793PhosphorylationSDYMAASSQLRLTEQ
HHHHHHHHHHHHHHH
28.6225159151
797UbiquitinationAASSQLRLTEQHFIE
HHHHHHHHHHHHHHH
9.3324816145
821UbiquitinationQKCKELMKRARQVCN
HHHHHHHHHHHHHHH
56.3724816145
895UbiquitinationTIVQEYTKREEEIEQ
HHHHHHHHCHHHHHH
57.84-
908UbiquitinationEQLTEELKGKKVELD
HHHHHHHCCCCCCHH
72.4732015554
911UbiquitinationTEELKGKKVELDQYR
HHHHCCCCCCHHHHH
50.0029967540
925UbiquitinationRENISQVKERWLNPL
HHHHHHHHHHHHHHH
33.6529967540
933UbiquitinationERWLNPLKELVEKIN
HHHHHHHHHHHHHHH
50.7029967540
979PhosphorylationRIRVKFRSSTQLHEL
EEEEEECCCCCCEEC
40.6520873877
980PhosphorylationIRVKFRSSTQLHELT
EEEEECCCCCCEECC
18.8628555341
981PhosphorylationRVKFRSSTQLHELTP
EEEECCCCCCEECCC
36.0728555341
987PhosphorylationSTQLHELTPHHQSGG
CCCCEECCCCCCCCC
20.0022067460
1025SulfoxidationVDEINQGMDPINERR
HCHHHCCCCCCCHHH
3.8921406390
1046PhosphorylationNTACKENTSQYFFIT
CHHHHCCCCCEEEEC
20.49-
1047PhosphorylationTACKENTSQYFFITP
HHHHCCCCCEEEECH
34.17-
1062PhosphorylationKLLQNLPYSEKMTVL
HHHCCCCCCCCEEEE
32.40-
1096PhosphorylationQRRRRRITFTQPS--
HHHHHCCEEECCC--
20.8623312004

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
-KUbiquitinationE3 ubiquitin ligaseXP03165
PMID:31167910

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of SMC5_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of SMC5_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
SMC6_HUMANSMC6physical
11408570
NSE2_HUMANNSMCE2physical
16055714
NSE1_HUMANNSMCE1physical
16055714

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of SMC5_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions.";
Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.;
Science 325:834-840(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-548, AND MASS SPECTROMETRY.
Phosphorylation
ReferencePubMed
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions.";
Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.;
Sci. Signal. 2:RA46-RA46(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-35, AND MASSSPECTROMETRY.
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-35, AND MASSSPECTROMETRY.

TOP